Patents by Inventor Min Ding

Min Ding has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compounds for the treatment of hepatitis C
    Patent number: 7541351
    Abstract: The invention encompasses compounds of formula I as well as compositions and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and are useful in treating those infected with HCV.
    Type: Grant
    Filed: January 9, 2008
    Date of Patent: June 2, 2009
    Assignee: Bristol-Myers Squibb Company
    Inventors: John A. Bender, Min Ding, Robert G. Gentles
  • Compounds for the treatment of hepatitis C
    Patent number: 7541353
    Abstract: The invention encompasses compounds of formula I as well as compositions and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and are useful in treating those infected with HCV.
    Type: Grant
    Filed: March 11, 2008
    Date of Patent: June 2, 2009
    Assignee: Bristol-Myers Squibb Company
    Inventors: Robert G. Gentles, Xiaofan Zheng, Min Ding, Yong Tu, Ying Han, Piyasena Hewawasam, John F. Kadow, John A. Bender, Kap-Sun Yeung, Katharine A. Grant-Young, Thomas W. Hudyma
  • Compounds for the treatment of Hepatitis C
    Patent number: 7538102
    Abstract: The invention encompasses compounds of Formula I, pharmaceutically acceptable salts thereof, compositions, and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and are useful in treating those infected with HCV.
    Type: Grant
    Filed: March 11, 2008
    Date of Patent: May 26, 2009
    Assignee: Bristol-Myers Squibb Company
    Inventors: Kap-Sun Yeung, John A. Bender, Robert G. Gentles, Zhong Yang, Min Ding, Yong Tu, Piyasena Hewawasam, Ying Han, John F. Kadow
  • Automated texture mapping system for 3D models
    Publication number: 20090110267
    Abstract: A camera pose may be determined automatically and is used to map texture onto a 3D model based on an aerial image. In one embodiment, an aerial image of an area is first determined. A 3D model of the area is also determined, but does not have texture mapped on it. To map texture from the aerial image onto the 3D model, a camera pose is determined automatically. Features of the aerial image and 3D model may be analyzed to find corresponding features in the aerial image and the 3D model. In one example, a coarse camera pose estimation is determined that is then refined into a fine camera pose estimation. The fine camera pose estimation may be determined based on the analysis of the features. When the fine camera pose is determined, it is used to map texture onto the 3D model based on the aerial image.
    Type: Application
    Filed: August 28, 2008
    Publication date: April 30, 2009
    Applicant: The Regents of the University of California
    Inventors: Avidoh Zakhor, Min Ding
  • Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors
    Patent number: 7521441
    Abstract: The invention encompasses compounds of formula I as well as compositions and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and are useful in treating those infected with HCV.
    Type: Grant
    Filed: May 7, 2007
    Date of Patent: April 21, 2009
    Assignee: Bristol-Myers Squibb Company
    Inventors: Robert G. Gentles, Piyasena Hewawasam, Min Ding, Carl P. Bergstrom, Scott W. Martin, Kap-Sun Yeung, Thomas W. Hudyma, Xiaofan Zheng, John A. Bender, John F. Kadow
  • Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors
    Patent number: 7521442
    Abstract: The invention encompasses compounds of formula I as well as compositions and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and are useful in treating those infected with HCV.
    Type: Grant
    Filed: May 23, 2007
    Date of Patent: April 21, 2009
    Assignee: Bristol-Myers Squibb Company
    Inventors: Robert G. Gentles, Min Ding, Piyasena Hewawasam
  • Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors
    Patent number: 7521443
    Abstract: The invention encompasses compounds of formula I as well as compositions and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and are useful in treating those infected with HCV.
    Type: Grant
    Filed: November 19, 2007
    Date of Patent: April 21, 2009
    Assignee: Bristol-Myers Squibb Company
    Inventors: John A. Bender, Min Ding, Robert G. Gentles, Piyasena Hewawasam
  • Manufacturing method of display panel and sealing layer material thereof
    Patent number: 7488230
    Abstract: A method of manufacturing a display panel is described. A substrate is provided. A wall structure is formed on the substrate to define several microcups. A display medium is filled into the microcups. Thereafter, a sealing layer is formed over the microcups filled with the display medium, wherein the sealing layer includes a first material that is immiscible with the display medium and a second material that is miscible with the display medium. A treatment process is performed such that the first material is solidified to form a solidifying layer while the second material miscible in the display medium undergoes a polymerization induced phase separation reaction so as to precipitate in the display medium.
    Type: Grant
    Filed: March 28, 2006
    Date of Patent: February 10, 2009
    Assignee: Industrial Technology Research Institute
    Inventors: Jau-Min Ding, Lung-Pin Hsin, Chi-Chang Liao
  • Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors
    Patent number: 7485633
    Abstract: The invention encompasses compounds of Formula I, pharmaceutically acceptable salts thereof, compositions, and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and are useful in treating those infected with HCV.
    Type: Grant
    Filed: March 12, 2007
    Date of Patent: February 3, 2009
    Assignee: Bristol-Myers Squibb Company
    Inventors: Nicholas A. Meanwell, Robert G. Gentles, Min Ding, John A. Bender, John F. Kadow, Piyasena Hewawasam, Thomas W. Hudyma, Xiaofan Zheng
  • Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors
    Patent number: 7456166
    Abstract: The invention encompasses compounds of formula I as well as compositions and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and are useful in treating those infected with HCV.
    Type: Grant
    Filed: May 3, 2007
    Date of Patent: November 25, 2008
    Assignee: Bristol-Myers Squibb Company
    Inventors: John A. Bender, Min Ding, Robert G. Gentles, Piyasena Hewawasam
  • Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors
    Patent number: 7452876
    Abstract: The invention encompasses compounds as well as compositions and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and are useful in treating those infected with HCV.
    Type: Grant
    Filed: May 31, 2007
    Date of Patent: November 18, 2008
    Assignee: Bristol-Myers Squibb Company
    Inventors: Kap-Sun Yeung, Katharine A. Grant-Young, Min Ding, Robert G. Gentles, John F. Kadow
  • Compounds for the Treatment of Hepatitis C
    Publication number: 20080226591
    Abstract: The invention encompasses compounds of formula I as well as compositions and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and are useful in treating those infected with HCV.
    Type: Application
    Filed: March 11, 2008
    Publication date: September 18, 2008
    Inventors: Robert G. Gentles, Xiaofan Zheng, Min Ding, Yong Tu, Ying Han, Piyasena Hewawasam, John F. Kadow, John A. Bender, Kap-Sun Yeung, Katharine A. Grant-Young, Thomas W. Hudyma
  • Compounds for the Treatment of Hepatitis C
    Publication number: 20080226592
    Abstract: The invention encompasses compounds of Formula I, pharmaceutically acceptable salts thereof, compositions, and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and are useful in treating those infected with HCV.
    Type: Application
    Filed: March 11, 2008
    Publication date: September 18, 2008
    Inventors: Kap-Sun Yeung, John A. Bender, Robert G. Gentles, Zhong Yang, Min Ding, Yong Tu, Piyasena Hewawasam, Ying Han, John F. Kadow
  • Compounds for the Treatment of Hepatitis C
    Publication number: 20080227769
    Abstract: The invention encompasses compounds of formula I, including pharmaceutically acceptable salts, as well as compositions and methods of using these compounds. The compounds have activity against hepatitis C virus (HCV) and are useful in treating those infected with HCV.
    Type: Application
    Filed: February 28, 2008
    Publication date: September 18, 2008
    Inventors: Robert G. Gentles, Xiaofan Zheng, Min Ding, Yong Tu, Ying Han, Piyasena Hewawasam, John F. Kadow, John A. Bender, Kap-Sun Yeung, Katharine A. Grant-Young, Thomas W. Hudyma
  • Compounds for the Treatment of Hepatitis C
    Publication number: 20080171015
    Abstract: The invention encompasses compounds of formula I as well as compositions and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and are useful in treating those infected with HCV.
    Type: Application
    Filed: January 9, 2008
    Publication date: July 17, 2008
    Inventors: John A. Bender, Min Ding, Robert G. Gentles
  • Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors
    Patent number: 7399758
    Abstract: The invention encompasses compounds of Formula I, pharmaceutically acceptable salts thereof, compositions, and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and are useful in treating those infected with HCV.
    Type: Grant
    Filed: August 22, 2006
    Date of Patent: July 15, 2008
    Inventors: Nicholas A. Meanwell, Robert G. Gentles, Min Ding, John A. Bender, John F. Kadow, Piyasena Hewawasam, Thomas W. Hudyma, Xiaofan Zheng
  • CYCLOPROPYL FUSED INDOLOBENZAZEPINE HCV NS5B INHIBITORS
    Publication number: 20080146537
    Abstract: The invention encompasses compounds of formula I as well as compositions and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and are useful in treating those infected with HCV.
    Type: Application
    Filed: November 19, 2007
    Publication date: June 19, 2008
    Inventors: John A. Bender, Min Ding, Robert G. Gentles, Piyasena Hewawasam
  • Inhibitors of HCV replication
    Patent number: 7348425
    Abstract: Indole compounds of Formula I are described. The compounds have activity against hepatitis C virus (HCV) and are useful in treating those infected with HCV.
    Type: Grant
    Filed: February 3, 2006
    Date of Patent: March 25, 2008
    Assignee: Bristol-Myers Squibb Company
    Inventors: Thomas W. Hudyma, Xiaofan Zheng, Feng He, Min Ding, Carl P. Bergstrom, Piyasena Hewawasam, Scott W. Martin, Robert G. Gentles
  • Transflective electrophoretic display device
    Patent number: 7339716
    Abstract: A transflective electrophoretic display device is disclosed. The device is comprised of a transparent top substrate and both top and bottom substrates have an electrode structure. A plurality of separated walls and an electrophoretic display solution including a plurality of chromatic particles and a transparent liquid are imposed between the two substrates. A device with a display liquid or a filter plate is used to generate a variety of lights such as monochromatic, color-level or true color having a mixture of red, green and blue. The device of the present invention integrates the merits of the reflective and transmitted displayer, and can be used outdoors, indoors or in darkness. Otherwise, a back light module can compensate for the contrast of the displayer effectively.
    Type: Grant
    Filed: October 20, 2005
    Date of Patent: March 4, 2008
    Assignee: Industrial Technology Research Institute
    Inventors: Jau-Min Ding, Chi-Chang Liao, Shie-Chang Jeng, Yi-Cheng Chen, Chih-Chiang Lu
  • MANUFACTURING METHOD AND STRUCTURE OF A DISPLAY PANEL
    Publication number: 20080036960
    Abstract: A method of manufacturing a display panel and a display panel are described. A first substrate is provided. A wall structure is formed on the first substrate to define several microcups. A displaying medium is filled into the microcups. Thereafter, a sealing material is formed over the microcups filled with the displaying medium. A second substrate is put over the sealing material and a lamination process is performed, wherein the sealing material which contacts the wall structure bonds the second substrate to the wall structure, and the sealing material which contacts the displaying medium dissolves in the displaying medium.
    Type: Application
    Filed: October 26, 2006
    Publication date: February 14, 2008
    Applicant: INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE
    Inventors: Jau-Min Ding, Yan-Rung Lin, Ru-De Chen, Chung-Hao Chen, I-Chun Chen, Chun-Yuan Lin, Wei-Hsin Hou